Notice of General Meeting, Proxy Form & Access Letter
Released
Released
Announcement PDF
Spenda Limited
ABN 67 099 084 143
Notice of General Meeting
Notice is hereby given that a General Meeting of Spenda Limited ACN 099 084 143 will be
held at Karstens Sydney, Level 1, 111 Harrington St, The Rocks NSW on Friday 8 May 2026 at
11:00am AEST.
The Explanatory Statement to this Notice of Meeting provides additional information on
matters to be considered at the Meeting. The Explanatory Statement and the Proxy Form are
part of this Notice of Meeting.
This Notice is given based on circumstances as at 2 April 2026. Should circumstances change,
the Company will make an announcement on the ASX market announcements platform (ASX
code: SPX) and on the Company’s website at https://investors.spenda.co. Shareholders are
urged to monitor the ASX announcements platform and the Company’s website for any
updates.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations
Regulations 2001 (Cth) that the persons eligible to vote at the General Meeting are those who
are registered Shareholders at 5:00PM AEST on 6 May 2026.
Terms and abbreviations used in this Notice of Meeting and Explanatory Statement are
defined in the Glossary or within this Notice.
This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how
they should vote, they should seek advice from their professional advisers prior to voting.
Voting
The business of the General Meeting affects your Shareholding and your vote is important.
Voting in person
To vote in person, attend the General Meeting on the date and at the place set out above.
Voting by proxy
To vote by proxy, please use one of the following methods:
2
Online Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by
following the instructions: Login to the Automic website using the holding details as
shown on the Proxy Form. Click on ‘View Meetings’ – ‘Vote’. To use the online
lodgement facility, Shareholders will need their holder number (Securityholder
Reference Number (SRN) or Holder Identification Number (HIN) as shown on the front
of the Proxy Form.
By post Automic, GPO Box 5193, Sydney NSW 2001
By hand Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
By email Completing the enclosed Proxy Form and emailing it to:
meetings@automicgroup.com.au
Your Proxy instruction must be received no later than 11:00am (AEST) on 6 May 2026, being
at least 48 hours before the commencement of the Meeting. Proxy Forms received later
than this time will be invalid.
Power of Attorney
If the Proxy Form is signed under a power of attorney on behalf of a Shareholder, then the
attorney must make sure that either the original power of attorney or a certified copy is sent
with the Proxy Form, unless the power of attorney has already provided it to the Share
Registry.
Corporate Representatives
If a representative of a corporate Shareholder or a corporate proxy will be attending the
Meeting, the representative should provide the Share Registry with adequate evidence of their
appointment, unless this has previously been provided to the Share Registry.
Agenda for the Meeting
Resolutions
Resolutions 1(a) and 1(b) – Ratification of prior issue of December Placement
Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate
ordinary resolution the following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the issue of:
(a) 32,914,167 December Placement Shares issued under Listing Rule 7.1; and
(b) 486,485,833 December Placement Shares issued under Listing Rule 7.1A,
on the terms and conditions set out in the Explanatory Statement.’
3
Resolution 2 – Approval to issue December Placement Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary
resolution, the following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes,
Shareholders approve the issue of up to 259,700,000 December Placement Options, on the terms
and conditions set out in the Explanatory Statement.’
Resolution 3 – Ratification of prior issue of March Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary
resolution, the following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the issue of 420,000,000 March Placement Shares issued under Listing Rule 7.1
on the terms and conditions in the Explanatory Statement.’
Resolutions 4 (a), 4(b), 4(c) and 4(d) – Approval to issue Related Party
March Placement Shares
To consider and, if thought fit, to pass with or without amendment, each as a separate
ordinary resolution the following:
‘That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes,
Shareholders approve the issue of up to 285,000,000 Related Party March Placement Shares to
the following Related Parties (or their respective nominee/s); as follows:
a) up to 155,000,000 Related Party March Placement Shares to Karim Razak (or his
nominee/s);
b) up to 50,000,000 Related Party March Placement Shares to Irshad Mulla (or his
nominee/s);
c) up to 5,000,000 Related Party March Placement Shares to Peter Richards (or his
nominee/s); and
d) up to 75,000,000 Related Party March Placement Shares to James Matthews (or his
nominee/s),
on the terms and conditions set out in the Explanatory Statement.’
4
Resolutions 5(a) and 5(b) – Approval to issue Options to Joint Lead Managers
To consider and, if thought fit, to pass with or without amendment, each as a separate
ordinary resolution the following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes,
Shareholders approve the issue of:
a) up to 20,000,000 December Broker Options to the Joint Lead Managers (or their
respective nominees); and
b) up to 20,000,000 March Broker Options to the Joint Lead Managers (or their
respective nominees),
on the terms and conditions set out in the Explanatory Statement’
Resolution 6 – Adoption of Employee Securities Incentive Plan
To consider and, if thought fit, to pass with or without amendment the following resolution
as an ordinary resolution:
“That, for the purposes of ASX Listing Rule 7.2 (Exception 13(b)) and for all other purposes, approval
is given for the Company to adopt an employee incentive scheme titled ‘Employee Securities
Incentive Plan’ and for the issue of securities under the Incentive Plan, on the terms and conditions
set out in the Explanatory Statement.”
Resolution 7 – Approval to Issue up to $1,500,000 worth of Shares
To consider and, if thought fit, to pass with or without amendment the following resolution
as an ordinary resolution:
"That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
authorise and approve the issue of up to the number of Shares determined by $1,500,000 divided
by the Share issue price on the terms and conditions set out in the Explanatory Statement."
Resolution 8 - Consolidation of capital
To consider and, if thought fit, to pass the following resolution as an ordinary resolution:
“That, for the purposes of section 254H of the Corporations Act and for all other purposes, the issued
capital of the Company be consolidated on the terms and conditions set out in the Explanatory
Statement and on the basis that:
(a) every twenty (20) Shares be consolidated into one (1) Consolidated Share; and
(b) all convertible Securities on issue be consolidated in accordance with Listing Rule 7.22.1;
and where this consolidation results in a fraction of a Security being held, the Company be
authorised to round that fraction up to the nearest whole Security.”
5
Voting Prohibitions and Exclusions
Resolutions 1a,
1b and 3
Voting Exclusion Statement: The Company will disregard any votes cast in favour
of by or on behalf of any person who participated in the issue of Equity Securities
referred to in each Resolution, or any of their respective associates.
However, this does not apply to a vote cast in favour by:
(a) a person as proxy or attorney for a person who is entitled to vote on
the Resolution, in accordance with directions given to the proxy or
attorney to vote on the Resolution in that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on
the Resolution, in accordance with a direction given to the Chair to
vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other
fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
• the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an Associate of a
person excluded from voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given
by the beneficiary to the holder to vote in that way.
Resolutions, 2,
5(a), 5(b) and 7.
Voting Exclusion Statement: The Company will disregard any votes cast in favour
of by or on behalf of any person who is expected to participate in, or who will obtain
a material benefit as a result of, the proposed issue (except a benefit solely by reason
of being a Shareholder), or any of their respective associates. However, this does not
apply to a vote cast in favour by:
(d) a person as proxy or attorney for a person who is entitled to vote on
the Resolution, in accordance with directions given to the proxy or
attorney to vote on the Resolution in that way; or
(e) the Chair as proxy or attorney for a person who is entitled to vote on
the Resolution, in accordance with a direction given to the Chair to
vote on the Resolution as the Chair decides; or
(f) a holder acting solely in a nominee, trustee, custodial or other
fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
• the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an Associate of a
person excluded from voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given
by the beneficiary to the holder to vote in that way.
Resolutions 4a,
4b, 4c and 4d
Voting Exclusion Statement: The Company will disregard any votes cast in favour
of the Resolution by or on behalf of the Related Party referred to in each Resolution
(or their respective his nominees) and any other person who will obtain a material
benefit as a result of the issue of the securities (except a benefit solely by reason of
6
being a holder of ordinary securities in the Company) or an associate of that person
or those persons.
However, this does not apply to a vote cast in favour by:
a) a person as proxy or attorney for a person who is entitled to vote on the
Resolution, in accordance with directions given to the proxy or attorney to
vote on the Resolution in that way; or
b) the Chair of the Meeting as proxy or attorney for a person who is entitled
to vote on the Resolution, in accordance with a direction given to the Chair
to vote on the Resolution as the Chair decides; or
c) a holder acting solely in a nominee, trustee, custodial or other fiduciary
capacity on behalf of a beneficiary provided the following conditions are
met:
• the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of a
person excluded from voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given
by the beneficiary to the holder to vote in that way.
Resolution 6 Voting Exclusion Statement: The Company will disregard any votes cast in favour
of this Resolution by or on behalf of:
(a) a person who is eligible to participate in the Incentive Plan; or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(i) a person as proxy or attorney for a person who is entitled to vote on the
Resolution, in accordance with directions given to the proxy or attorney to
vote on the Resolution in that way; or
(ii) the Chair as proxy or attorney for a person who is entitled to vote on the
Resolution, in accordance with a direction given to the Chair to vote on the
Resolution as the Chair decides; or
(iii) a holder acting solely in a nominee, trustee, custodial or other fiduciary
capacity on behalf of a beneficiary provided the following conditions are met:
• the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an Associate of a
person excluded from voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given by
the beneficiary to the holder to vote in that way.
Voting Prohibition Statement: In accordance with section 250BD of the
Corporations Act, a person appointed as a proxy must not vote, on the basis of
that appointment, on this Resolution if:
(a) the proxy is a Restricted Voter; and
7
(b) the appointment does not specify the way the proxy is to vote on the
Resolution.
However, the above prohibition does not apply if:
• the proxy is the Chair; and
• the appointment expressly authorises the Chair to exercise the proxy even if
the Resolution is connected directly or indirectly with remuneration of a
member of the Key Management Personnel.
Determination of voting entitlement
For the purpose of determining a person’s entitlement to vote at the Meeting, a person will be
recognised as a shareholder and the holder of Shares if that person is registered as a holder
of those Shares at 5:00pm AEST on 6 May 2026.
Votes
Voting on each resolution will be by way of a poll, every member present in person or by
attorney or by proxy or, in the case of a body corporate, by a representative, shall have one
vote for each share held by him, her or it.
On a poll, every member present in person or by attorney or by proxy or, in the case of a body
corporate, by a representative, shall have one vote for each share held by him, her or it.
Proxies
A Shareholder entitled to attend and vote is entitled to appoint a proxy to attend and vote
instead of the Shareholder.
Where the Shareholder is entitled to cast two or more votes, the Shareholder may appoint
two proxies and may specify the proportion or number of votes each proxy is appointed to
exercise.
If the Shareholder appoints two proxies and the appointment does not specify the proportion
or number of the Shareholder’s votes each proxy may exercise, each proxy may exercise half
of the votes. A proxy need not be a Shareholder.
To be effective, the instrument of appointment of a proxy (and power of attorney or other
authority, if any, under which it is signed or a certified copy of that power or authority) must
be received by the Company, by mail at Automic GPO Box 5193, Sydney NSW 2001, in person
Level 5, 126 Phillip Street Sydney NSW 200, by email at meetings@automicgroup.com.au or
online at https://investor.automic.com.au/#/loginsah by 48 hours prior to commencement of
the Meeting.
8
If you choose to appoint a proxy, you are encouraged to direct your proxy how to vote on the
Resolutions by marking either “For”, “Against” or “Abstain” on the form of proxy for that item
of business.
Subject to the voting restrictions set out in the Voting Exclusion Statements, the Chairperson
will vote undirected proxies on, and in favour of Resolutions 1 to 8.
A form of proxy accompanies this Notice.
Questions and Comments by Shareholders
If you have any questions in regard to this Notice, please contact the Company at
investors@spenda.co.
9
EXPLANATORY STATEMENT
This Explanatory Statement has been prepared for the information of the Shareholders in
connection with the business to be conducted at the General Meeting to be held at 11:00 am
(AEST) on Friday, 8 May 2026 at Karstens Sydney, Level 1, 111 Harrington St, The Rocks NSW
(Meeting).
The purpose of this Explanatory Statement is to provide information which the Directors
believe to be material to Shareholders in deciding whether to pass the Resolutions in the
Notice of Meeting.
If you are in any doubt about what to do in relation to the Resolutions contemplated in the
Notice of Meeting and this Explanatory Statement, it is recommended that you seek advice
from an accountant, solicitor or other professional advisor.
Full details of the business to be considered at the General Meeting are set out below.
Agenda
Ordinary business
Resolutions
1. Resolution 1– Ratification of prior issue of December
Placement Shares
1.1. Background to the December Placement
On 16 December 2025, the Company completed a placement to new and existing
sophisticated and professional investors to raise a total of $1,298,500 (before costs)
through the issue of 519,400,000 Shares (December Placement Shares) at an issue
price of $0.0025 per December Placement Share (December Placement). Participants
in the December Placement will also, in addition, to each two Shares subscribed for,
receive one free attaching Option with an exercise price of $0.005 (0.5 cents) per Option
expiring 31 January 2028, subject to shareholder approval (December Placement
Options).
The terms of the December Placement Options are set out in Annexure A and their
issue is subject to the approval of Resolution 2 in this Notice.
32,914,167 of the December Placement Shares were issue without prior Shareholder
approval issued under Listing Rule 7.1 and 486,485,833 December Placement Shares
were without prior approval issued under Listing Rule 7.1A.
Lodge Corporate Pty Ltd (“Lodge”) and Lynx Advisors Pty Ltd (“Lynx”) acted as Joint Lead
Managers (“JLM”) to the December Placement. The JLM will receive fees of 6% on funds
raised from their clients and will receive 20,000,000 broker options, with an exercise
price of $0.005 per option expiring 31 January 2028 (“December Broker Options”). The
10
terms of the December Broker Options are set out in Annexure A and their issue is
subject to the approval of Resolution 5(a) in this Notice.
Resolutions 1(a) and 1(b) seeks Shareholder approval pursuant to Listing Rule 7.4 to
ratify the issue of the December Placement Shares under Listing Rule 7.1 and 7.1A
respectively.
1.2. Listing Rules 7.1, 7.1A and 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the
amount of Equity Securities that a listed company can issue without the approval of its
shareholders over any 12-month period to 15% of the fully paid ordinary shares it has
on issue at the start of that period.
Under Listing Rule 7.1A however, an eligible entity can seek approval from its members,
by way of a special resolution passed at its annual general meeting, to increase this 15%
limit by an extra 10% to 25%. The Company obtained this approval at its annual general
meeting held on 27 November 2025.
The issue of the December Placement Shares does not fit without any of the exceptions
to Listing Rule 7.1 and 7.1A and, as it has not yet been approved by Shareholders,
effectively uses up part of the Company’s 15% placement capacity under Listing Rule 7.1
and 10% placement capacity under Listing Rul 7.1A. This reduces the Company’s
capacity to issue further Equity Securities without Shareholder approval under those
Listing Rules for the 12 month period following the issue of the Tranche 1 Placement
Shares.
Listing Rule 7.4 provides an exception to Listing Rules 7.1 and 7.1A. It provides that
where a company in a general meeting ratifies the previous issue of securities made
pursuant to Listing Rule 7.1 and 7.1A (and provided the previous issue did not breach
Listing Rule 7.1 and 7.1A), those securities will be deemed to have been made with
shareholder approval for the purposes of Listing Rule 7.1 and 7.1A.
The effect of Shareholders passing Resolution 1(a) and 1(b) will be to allow the Company
to retain the flexibility to issue Equity Securities in the future up to the 15% placement
capacity set out in Listing Rule 7.1, and the 10% additional placement capacity set out in
Listing Rule 7.1A, without the requirement to obtain prior Shareholder approval.
If Resolution 1(a) is passed, 32,914,167 December Placement Shares will be excluded in
calculating the Company’s 15% limit under Listing Rule 7.1, effectively increasing the
number of Equity Securities it can issue without Shareholder approval over the 12
month period following the issue of those December Placement Shares.
If Resolution 1(b) is passed, 486,485,833 December Placement Shares will be excluded in
calculating the Company’s 10% limit under Listing Rule 7.1A, effectively increasing the
number of Equity Securities it can issue without Shareholder approval over the 12
month period following the issue of those December Placement Shares.
11
If Resolution 1(a) is not passed, 32,914,167 December Placement Shares will continue to
be included in the Company’s 15% limit under Listing Rule 7.1, effectively decreasing the
number of Equity Securities the Company can issue or agree to issue without obtaining
prior Shareholder approval, to the extent of 32,914,167 Equity Securities for the 12
month period following the issue of those December Placement Shares.
If Resolution 1(b) is not passed, 486,485,833 December Placement Shares will continue
to be included in the Company’s 10% limit under Listing Rule 7.1A, effectively decreasing
the number of Equity Securities the Company can issue or agree to issue without
obtaining prior Shareholder approval, to the extent of 486,485,833 Equity Securities for
the 12 month period following the issue of those Tranche 1 Placement Shares (and
assuming the Company's approval under Listing Rule 7.1A remains in force for this
period).
The Company confirms that Listing Rules 7.1 and 7.1A were not breached at time the
December Placement Shares were issued.
1.3. Specific Information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is
provided in relation to the ratification of the issue of the December Placement Shares:
(a) The December Placement Shares were issued to a range of new and existing
sophisticated and professional investors (December Placement
Participants). The December Placement Participants were identified through
a bookbuild process, which involved the Joint Lead Managers seeking
expressions of interest to participate in the Placement from new and existing
contacts of the Company and clients of the Joint Lead Managers. None of the
December Placement Shares were issued to related parties or Material
Investors of the Company.
(b) On 16 December 2025, the Company issued a total of 519,400,000 December
Placement Shares using the Company’s available placement capacity in the
following proportions:
(i) 32,914,167 December Placement Shares issued under Listing Rule 7.1;
and
(ii) 486,485,833 December Placement Shares issued under Listing Rule
7.1A.
(c) The December Placement Shares are fully paid ordinary shares in the capital
of the Company and rank equally in all respects with the Company’s existing
Shares on issue.
(d) The December Placement Shares were issued at $0.0025 each.
12
The proceeds from the issue of the December Placement Shares have been used towards
product development, reduction of debt, general working capital the costs of the December
Placement.
(e) There are no other material terms to the agreement for the issue of the
December Placement Shares.
(f) A voting exclusion statement is included in the Notice.
1.4. Directors’ Recommendation
The Board recommends Shareholders vote in favour of this Resolution.
Where permitted, the Chair intends to vote all undirected proxies in favour of this Resolution.
2. Resolution 2 - Approval to issue December Placement
Options
2.1. Background
The background to the December Placement and the issue of December Placement Options
is set out in section 1.2 of this Notice.
Resolution 2 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of up to
259,700,000 December Placement Options to the December Placement Participants.
2.2. Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 1.2 above.
The proposed issue of the Placement Options does not fit within any of the exceptions to
Listing Rule 7.1 and exceeds the Company’s 15% limit in Listing Rule 7.1. It therefore requires
the approval of the Company’s Shareholders under Listing Rule 7.1.
The effect of Shareholders passing Resolution 2 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 2 is passed, the Company can proceed to issue the 259,700,000 December
Placement Options without using up any of the Company's 15% limit on issuing Equity
Securities without shareholder approval under Listing Rule 7.1, effectively increasing the
number of Equity Securities it can issue without Shareholder approval over the 12 month
period following the issue date.
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the
259,700,000 December Placement Options.
2.3. Specific Information required by Listing Rule 7.3
13
Pursuant to and in accordance with Listing Rule 7.3, the following information is
provided in relation to the to the proposed issue of the December Placement
Options:
a) The December Placement Options will be issued to the December Placement
Participants. None of the of the December Placement Options will be issued to
related parties or Material Investors of the Company.
b) A maximum of 259,700,000 Placement Options will be issued.
c) The Placement Options are exercisable at $0.005 each and expire 31 January
2028. The Company will not apply to ASX for official quotation of the December
Placement Options. The December Placement Options are otherwise subject to
the terms and conditions set out in Annexure A.
d) The December Placement Options will be issued no later than 3 months after the
date of the Meeting.
e) As the December Placement Options are free attaching based on one (1)
Placement Option for every two (2) December Placement Shares subscribed for
and issued under the December Placement, the Company will not receive any cash
consideration for the issue of the December Placement Options.
f) A summary of the intended use of funds raised from the December Placement is
set out in Section 1.3 above. No additional funds will be raised by the issue of
the December Placement Options. Any funds raised upon exercise of the
December Placement Options will be used towards general working capital
purposes.
g) The purpose of the issue of the December Placement Options was to incentivise
participation in the December Placement.
h) There are no other material terms to the proposed issue of the December
Placement Options.
i) A voting exclusion statement is included in the Notice.
2.4. Directors’ recommendation
The Board recommends Shareholders vote in favour of this Resolution.
Where permitted, the Chair intends to vote all undirected proxies in favour of this Resolution.
3. Resolution 3 – Ratification of prior issue of March
Placement Shares
3.1. Background to the March Placement
On 6 March 2026, the Company announced a placement to new and existing sophisticated
14
and professional investors. The placement will raise a total of $1,410,000 (before costs)
through the issue of 705,000,000 Shares (March Placement Shares) at an issue price of
$0.002 per March Placement Share (March Placement).
420,000,000 of the March Placement Shares were issue without prior Shareholder approval
under Listing Rule 7.1 in March 2026.
Spenda Directors Karim Razak ($310,000), Irshad Mulla ($100,000), Peter Richards ($10,000)
and former director, now Chief Marketing Officer, James Matthews ($150,000) will participate
in the March Placement subscribing for a combined $570,000 or 285,000,000 March
Placement Shares subject to shareholder approval for the purpose of ASX Listing Rule 10.11.
The issue of these 285,000,000 March Placement Shares is the subject of Resolutions 4(a) to
4(d).
Lodge Corporate Pty Ltd (“Lodge”) and Lynx Advisors Pty Ltd (“Lynx”) acted as Joint Lead
Managers (“JLM”) to the March Placement. The JLM will receive fees of 6% on funds raised
from their clients and will receive 20,000,000 broker options, with an exercise price of $0.007
per option expiring 31 January 2030 (“March Broker Options”). The terms other of the March
Broker Options are set out in Annexure B and their issue is subject to the approval of
Resolution 5b in this Notice.
This Resolutions seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the issue
of the 420,000,000 March Placement Shares under Listing Rule 7.1 in March 2026.
3.2. Listing Rules 7.1, 7.1A and 7.4
A summary of Listing Rules 7.1, 7.1A and 7.4 is set out previously in this Notice in Section
1.2.
The effect of Shareholders passing Resolution 3 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 3 is passed, 420,000,000 March Placement Shares will be excluded in calculating
the Company’s 15% limit under Listing Rule 7.1, effectively increasing the number of Equity
Securities it can issue without Shareholder approval over the 12 month period following the
issue of those March Placement Shares.
If Resolution 3 is not passed, 420,000,000 March Placement Shares will continue to be
included in the Company’s 15% limit under Listing Rule 7.1, effectively decreasing the
number of Equity Securities the Company can issue or agree to issue without obtaining prior
Shareholder approval, to the extent of 420,000,000 Equity Securities for the 12 month period
following the issue of those December Placement Shares.
The Company confirms tha
Share your feedback
Discover